Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock

详细信息    查看全文

• 作者：H Bryant Nguyen (5) (6)
  Manisha Loomba (3)
  James J Yang (4)
  Gordon Jacobsen (4)
  Kant Shah (1)
  Ronny M Otero (1)
  Arturo Suarez (1)
  Hemal Parekh (6)
  Anja Jaehne (1)
  Emanuel P Rivers (1) (2)
  
• 刊名：Journal of Inflammation
• 出版年：2010
• 出版时间：December 2010
• 年：2010
• 卷：7
• 期：1
• 全文大小：410KB
• 参考文献：1. Karimova A, Pinsky DJ: The endothelial response to oxygen deprivation: biology and clinical implications. / Intensive Care Med 2001, 27: 19鈥?1. href="http://dx.doi.org/10.1007/s001340000790">CrossRef
  2. Rivers EP, Kruse JA, Jacobsen G, Shah K, Loomba M, Otero R, Childs EW: The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock. / Crit Care Med 2007, 35: 2016鈥?4. href="http://dx.doi.org/10.1097/01.CCM.0000281637.08984.6E">CrossRef
  3. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. / Crit Care Med 2001, 29: S99鈥?06. href="http://dx.doi.org/10.1097/00003246-200107001-00032">CrossRef
  4. Marshall JC, Vincent JL, Fink MP, Cook DJ, Rubenfeld G, Foster D, Fisher CJ Jr, Faist E, Reinhart K: Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25鈥?6, 2000. / Crit Care Med 2003, 31: 1560鈥?. href="http://dx.doi.org/10.1097/01.CCM.0000065186.67848.3A">CrossRef
  5. Nadiri A, Wolinski MK, Saleh M: The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. / J Immunol 2006, 177: 4239鈥?5.
  6. Trzeciak S, Rivers EP: Emergency department overcrowding in the United States: an emerging threat to patient safety and public health. / Emerg Med J 2003, 20: 402鈥?. href="http://dx.doi.org/10.1136/emj.20.5.402">CrossRef
  7. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. / N Engl J Med 2001, 345: 1368鈥?7. href="http://dx.doi.org/10.1056/NEJMoa010307">CrossRef
  8. Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, Kline JA: The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. / Crit Care Med 2008, 36: 2734鈥?. href="http://dx.doi.org/10.1097/CCM.0b013e318186f839">CrossRef
  9. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. / Crit Care Med 2008, 36: 296鈥?27. href="http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41">CrossRef
  10. Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA: Tomlanovich MC. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. / Crit Care Med 2004, 32: 1637鈥?2. href="http://dx.doi.org/10.1097/01.CCM.0000132904.35713.A7">CrossRef
  11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis / Crit Care Med 1992, 20: 864鈥?4.
  12. Cohen J: The immunopathogenesis of sepsis. / Nature 2002, 420: 885鈥?1. href="http://dx.doi.org/10.1038/nature01326">CrossRef
  13. Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). / Circulation 1970, 41: 989鈥?001.
  14. Kompanje EJ, Jansen TC, Hoven B, Bakker J: The first demonstration of lactic acid in human blood in shock by Johann Joseph Scherer (1814鈥?869) in January 1843. Intensive. / Care Med 2007, 33: 1967鈥?1. href="http://dx.doi.org/10.1007/s00134-007-0788-7">CrossRef
  15. Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ: Serial lactate determinations during circulatory shock. / Crit Care Med 1983, 11: 449鈥?1. href="http://dx.doi.org/10.1097/00003246-198306000-00012">CrossRef
  16. Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL: Serial blood lactate levels can predict the development of multiple organ failure following septic shock. / Am J Surg 1996, 171: 221鈥?. href="http://dx.doi.org/10.1016/S0002-9610(97)89552-9">CrossRef
  17. James JH, Luchette FA, McCarter FD, Fischer JE: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. / Lancet 1999, 354: 505鈥?. href="http://dx.doi.org/10.1016/S0140-6736(98)91132-1">CrossRef
  18. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. / Crit Care Med 2009, 37: 1670鈥?. href="http://dx.doi.org/10.1097/CCM.0b013e31819fcf68">CrossRef
  19. Yang CS, Qiu HB, Huang YZ, Xie JF, Mo M, Liu SQ, Yang Y: Prospective research on the prognosis of septic shock based on the change of lactate concentration in arterial blood. / Zhonghua Wai Ke Za Zhi 2009, 47: 685鈥?.
  20. Seear MD, Scarfe JC, LeBlanc JG: Predicting major adverse events after cardiac surgery in children. / Pediatr Crit Care Med 2008, 9: 606鈥?1. href="http://dx.doi.org/10.1097/PCC.0b013e31818d1971">CrossRef
  21. Basaran M, Sever K, Kafali E, Ugurlucan M, Sayin OA, Tansel T, Alpagut U, Dayioglu E, Onursal E: Serum lactate level has prognostic significance after pediatric cardiac surgery. / J Cardiothorac Vasc Anesth 2006, 20: 43鈥?. href="http://dx.doi.org/10.1053/j.jvca.2004.10.010">CrossRef
  22. Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, Brodaty D: Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery. / Chest 2003, 123: 1361鈥?. href="http://dx.doi.org/10.1378/chest.123.5.1361">CrossRef
  23. Rady MY, Rivers EP, Martin GB, Smithline H, Appleton T, M NR: Continuous central venous oximetry and shock index in the emergency department: use in the evaluatio of clinical shock. / American Journal of Emergency Medicine 1992, 10: 538鈥?1. href="http://dx.doi.org/10.1016/0735-6757(92)90178-Z">CrossRef
  24. Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, Laggner AN: Serial lactate determinations for prediction of outcome after cardiac arrest. / Medicine (Baltimore) 2004, 83: 274鈥?. href="http://dx.doi.org/10.1097/01.md.0000141098.46118.4c">CrossRef
  25. Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J: Lactate clearance and survival following injury. / J Trauma 1993, 35: 584鈥?. discussion 588鈥? href="http://dx.doi.org/10.1097/00005373-199310000-00014">CrossRef
  26. McNelis J, Marini CP, Jurkiewicz A, Szomstein S, Simms HH, Ritter G, Nathan IM: Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. / Am J Surg 2001, 182: 481鈥?. href="http://dx.doi.org/10.1016/S0002-9610(01)00755-3">CrossRef
  27. Watanabe I, Mayumi T, Arishima T, Takahashi H, Shikano T, Nakao A, Nagino M, Nimura Y, Takezawa J: Hyperlactemia can predict the prognosis of liver resection. / Shock 2007, 28: 35鈥?. href="http://dx.doi.org/10.1097/shk.0b013e3180310ca9">CrossRef
  28. Antonelli M, Levy M, Andrews PJ, Chastre J, Hudson LD, Manthous C, Meduri GU, Moreno RP, Putensen C, Stewart T, Torres A: Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27鈥?8 April 2006. / Intensive Care Med 2007, 33: 575鈥?0. href="http://dx.doi.org/10.1007/s00134-007-0531-4">CrossRef
  29. Aduen J, Bernstein WK, Khastgir T, Miller J, Kerzner R, Bhatiani A, Lustgarten J, Bassin AS, Davison L, Chernow B: The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations. / JAMA 1994, 272: 1678鈥?5. href="http://dx.doi.org/10.1001/jama.272.21.1678">CrossRef
  30. Levy MM, Macias WL, Vincent JL, Russell JA, Silva E, Trzaskoma B, Williams MD: Early changes in organ function predict eventual survival in severe sepsis. / Crit Care Med 2005, 33: 2194鈥?201. href="http://dx.doi.org/10.1097/01.CCM.0000182798.39709.84">CrossRef
  31. De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. / Crit Care Med 2006, 34: 1918鈥?4. href="http://dx.doi.org/10.1097/01.CCM.0000220498.48773.3C">CrossRef
  32. Shreeniwas R, Koga S, Karakurum M, Pinsky D, Kaiser E, Brett J, Wolitzky BA, Norton C, Plocinski J, Benjamin W, / et al.: Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. / J Clin Invest 1992, 90: 2333鈥?. href="http://dx.doi.org/10.1172/JCI116122">CrossRef
  33. Yan SF, Tritto I, Pinsky D, Liao H, Huang J, Fuller G, Brett J, May L, Stern D: Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. / J Biol Chem 1995, 270: 11463鈥?1. href="http://dx.doi.org/10.1074/jbc.270.19.11463">CrossRef
  34. Karakurum M, Shreeniwas R, Chen J, Pinsky D, Yan SD, Anderson M, Sunouchi K, Major J, Hamilton T, Kuwabara K, / et al.: Hypoxic induction of interleukin-8 gene expression in human endothelial cells. / J Clin Invest 1994, 93: 1564鈥?0. href="http://dx.doi.org/10.1172/JCI117135">CrossRef
  35. Leeper-Woodford SK, Fisher BJ, Sugerman HJ, Fowler AAd: Pharmacologic reduction in tumor necrosis factor activity of pulmonary alveolar macrophages. / Am J Respir Cell Mol Biol 1993, 8: 169鈥?5.
  36. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. / Cytokine 1991, 3: 189鈥?4. href="http://dx.doi.org/10.1016/1043-4666(91)90015-6">CrossRef
  37. Toda K, Kayano K, Karimova A, Naka Y, Fujita T, Minamoto K, Wang CY, Pinsky DJ: Antisense intercellular adhesion molecule-1 (ICAM-1) oligodeoxyribonucleotide delivered during organ preservation inhibits posttransplant ICAM-1 expression and reduces primary lung isograft failure. / Circ Res 2000, 86: 166鈥?4.
  38. Wang CY, Naka Y, Liao H, Oz MC, Springer TA, Gutierrez-Ramos JC, Pinsky DJ: Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. / Circ Res 1998, 82: 762鈥?2.
  39. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ: Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. / J Clin Invest 1995, 95: 2720鈥?. href="http://dx.doi.org/10.1172/JCI117974">CrossRef
  40. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. / Blood 1989, 74: 1704鈥?0.
  41. Hack CE, Hart M, van Schijndel RJ, Eerenberg AJ, Nuijens JH, Thijs LG, Aarden LA: Interleukin-8 in sepsis: relation to shock and inflammatory mediators. / Infect Immun 1992, 60: 2835鈥?2.
  42. Phua J, Koay ES, Lee KH: Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. / Shock 2008, 29: 328鈥?3. href="http://dx.doi.org/10.1097/SHK.0b013e318150716b">CrossRef
  43. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE: High-mobility group box 1 protein plasma concentrations during septic shock. / Intensive Care Med 2007, 33: 1347鈥?3. href="http://dx.doi.org/10.1007/s00134-007-0691-2">CrossRef
  44. Sama AE, D'Amore J, Ward MF, Chen G, Wang H: Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. / Acad Emerg Med 2004, 11: 867鈥?3.
  45. Levi M, ten Cate H, Poll T, van Deventer SJ: Pathogenesis of disseminated intravascular coagulation in sepsis. / Jama 1993, 270: 975鈥?. href="http://dx.doi.org/10.1001/jama.270.8.975">CrossRef
  46. Kobayashi S, Gando S, Morimoto Y, Nanzaki S, Kemmotsu O: Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. / Surg Today 2001, 31: 853鈥?. href="http://dx.doi.org/10.1007/s005950170022">CrossRef
  47. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, Garcia-Avello A: Time course of hemostatic abnormalities in sepsis and its relation to outcome. / Chest 1993, 103: 1536鈥?2. href="http://dx.doi.org/10.1378/chest.103.5.1536">CrossRef
  48. Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS: D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. / Chest 2002, 121: 1262鈥?. href="http://dx.doi.org/10.1378/chest.121.4.1262">CrossRef
  49. Quick G, Eisenberg P: Bedside measurement of D-dimer in the identification of bacteremia in the emergency department. / J Emerg Med 2000, 19: 217鈥?3. href="http://dx.doi.org/10.1016/S0736-4679(00)00230-4">CrossRef
  50. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr: Efficacy and safety of recombinant human activated protein C for severe sepsis. / N Engl J Med 2001, 344: 699鈥?09. href="http://dx.doi.org/10.1056/NEJM200103083441001">CrossRef
  51. Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE: Endothelial cell apoptosis in sepsis. / Crit Care Med 2002, 30: S225鈥?. href="http://dx.doi.org/10.1097/00003246-200205001-00009">CrossRef
  52. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL: Apoptosis in sepsis: a new target for therapeutic exploration. / Faseb J 2001, 15: 879鈥?2. href="http://dx.doi.org/10.1096/fj.00-058rev">CrossRef
  53. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, Strasser A, Hotchkiss RS: Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. / Faseb J 2007, 21: 708鈥?9. href="http://dx.doi.org/10.1096/fj.06-6805com">CrossRef
  54. Brunelle JK, Chandel NS: Oxygen deprivation induced cell death: an update. / Apoptosis 2002, 7: 475鈥?2. href="http://dx.doi.org/10.1023/A:1020668923852">CrossRef
  55. Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. / Crit Care Med 2004, 32: 2173鈥?2.
  56. Opal SM, Fisher CJ Jr, Dhainaut JF, Vincent JL, Brase R, Lowry SF, Sadoff JC, Slotman GJ, Levy H, Balk RA, Shelly MP, Pribble JP, LaBrecque JF, Lookabaugh J, Donovan H, Dubin H, Baughman R, Norman J, DeMaria E, Matzel K, Abraham E, Seneff M: Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. / Crit Care Med 1997, 25: 1115鈥?4. href="http://dx.doi.org/10.1097/00003246-199707000-00010">CrossRef
  57. Sevransky JE, Nour S, Susla GM, Needham DM, Hollenberg S, Pronovost P: Hemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature. / Crit Care 2007, 11: R67. href="http://dx.doi.org/10.1186/cc5948">CrossRef
  
• 作者单位：H Bryant Nguyen (5) (6)
  Manisha Loomba (3)
  James J Yang (4)
  Gordon Jacobsen (4)
  Kant Shah (1)
  Ronny M Otero (1)
  Arturo Suarez (1)
  Hemal Parekh (6)
  Anja Jaehne (1)
  Emanuel P Rivers (1) (2)
  
  5. Department of Emergency Medicine, Loma Linda University, Loma Linda, CA
  6. Department of Internal Medicine, Pulmonary and Critical Care Medicine, Loma Linda University, Loma Linda, CA
  3. Department of Anesthesiology, Henry Ford Hospital, Detroit, MI, USA
  4. Department of Biostatistics and Epidemiology, Henry Ford Hospital, Detroit, MI, USA
  1. Department of Emergency Medicine, Henry Ford Hospital, Detroit, MI, USA
  2. Department of Surgery, Henry Ford Hospital, Detroit, MI, USA
  
• ISSN：1476-9255

文摘

Background Lactate clearance, a surrogate for the magnitude and duration of global tissue hypoxia, is used diagnostically, therapeutically and prognostically. This study examined the association of early lactate clearance with selected inflammatory, coagulation, apoptosis response biomarkers and organ dysfunction scores in severe sepsis and septic shock. Methods Measurements of serum arterial lactate, biomarkers (interleukin-1 receptor antagonist, interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-alpha, intercellular adhesion molecule-1, high mobility group box-1, D-Dimer and caspase-3), and organ dysfunction scores (Acute Physiology and Chronic Health Evaluation II, Simplified Acute Physiology Score II, Multiple Organ Dysfunction Score, and Sequential Organ Failure Assessment) were obtained in conjunction with a prospective, randomized study examining early goal-directed therapy in severe sepsis and septic shock patients presenting to the emergency department (ED). Lactate clearance was defined as the percent change in lactate levels after six hours from a baseline measurement in the ED. Results Two-hundred and twenty patients, age 65.0 +/- 17.1 years, were examined, with an overall lactate clearance of 35.5 +/- 43.1% and in-hospital mortality rate of 35.0%. Patients were divided into four quartiles of lactate clearance, -24.3 +/- 42.3, 30.1 +/- 7.5, 53.4 +/- 6.6, and 75.1 +/- 7.1%, respectively (p < 0.01). The mean levels of all biomarkers and organ dysfunction scores over 72 hours were significantly lower with higher lactate clearance quartiles (p < 0.01). There was a significant decreased in-hospital, 28-day, and 60-day mortality in the higher lactate clearance quartiles (p < 0.01). Conclusions Early lactate clearance as a surrogate for the resolution of global tissue hypoxia is significantly associated with decreased levels of biomarkers, improvement in organ dysfunction and outcome in severe sepsis and septic shock.